| Idebenone for Primary Progressive Multiple Sclerosis (NCT01854359) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-03-12 |
| Influence of High Intensity Exercise on Insulin Resistance, Muscle Contractile Properties, Aerobic Capacity and Body Composition in Multiple Sclerosis (NCT01845896) | Bert Op't Eijnde | 2013-03-01 |
| An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis (NCT01803867) | Acorda Therapeutics | 2013-03-01 |
| Vitamine D in Multiple Sclerosis (NCT01768039) | Mazandaran University of Medical Sciences | 2013-03-01 |
| Anesthetic Topical Adhesive (Synera™) to Reduce Injection Pain With Subcutaneous Multiple Sclerosis Medications (NCT01834586) | Brown, Theodore R., M.D., MPH | 2013-03-01 |
| Investigation of GM Pathology Using Ultra High Field (7T) MRI Scanner (NCT01805986) | University of Nottingham | 2013-03-01 |
| Stylistic Memory Enhancement (NCT03206034) | Kessler Foundation | 2013-03-01 |
| A Phase 4 Study to Assess the Impact of Patient Support Program on Health Related Quality of Life and Adherence in Subjects With Relapsing-Remitting Multiple Sclerosis Administered Rebif® With the RebiSmart™ Device (NCT01791244) | Merck KGaA, Darmstadt, Germany | 2013-02-28 |
| The Efficacy, Safety, and Tolerability of Laquinimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) (NCT01707992) | Teva Branded Pharmaceutical Products R&D, Inc. | 2013-02-20 |
| Long-Term Extension Study in Participants With Multiple Sclerosis Who Have Completed Study 205MS301 (NCT01064401) to Evaluate the Safety and Efficacy of BIIB019 (NCT01797965) | Biogen | 2013-02-15 |
| Power Over Pain (POP) Study (NCT01800604) | University of Washington | 2013-02-01 |
| Amiloride Clinical Trial In Optic Neuritis (NCT01802489) | University of Oxford | 2013-02-01 |
| Study Evaluating Rapid Infusion Rituximab in Patients With Autoimmune Diseases (NCT02040116) | Wake Forest University Health Sciences | 2013-02-01 |
| Mesenchymal Stem Cells for Multiple Sclerosis (NCT01730547) | Karolinska Institutet | 2013-02-01 |
| Observational Study for Assessment of the Effect of Fampyra on the Manual Function of Persons With Multiple Sclerosis (NCT01547234) | Carmel Medical Center | 2013-02-01 |
| Intensive Multimodal Training for Persons With MS (NCT03271125) | Fondazione Don Carlo Gnocchi ETS | 2013-01-08 |
| GSK239512 DDI Study (NCT01802931) | GlaxoSmithKline | 2013-01-07 |
| Health Promotion and Wellness Program for Adults With Disabling Conditions (NCT01776034) | Case Western Reserve University | 2013-01-01 |
| Effects of Cognitive Behavioural Therapy and Exercise on Stress and Cognitive Deficits in Multiple Sclerosis (NCT01763983) | Sunnybrook Health Sciences Centre | 2013-01-01 |
| Adherence in Pediatric Multiple Sclerosis (NCT02234713) | The Hospital for Sick Children | 2013-01-01 |
| Effects of Repeated Mesenchymal Stem Cells (MSC) in Patients With Progressive Multiple Sclerosis (NCT04823000) | Hadassah Medical Organization | 2013-01-01 |
| Role of Vitamin D in Reducing the Relapse Rate in Patients With Multiple Sclerosis (NCT01753375) | AlJohara M AlQuaiz, M.D. | 2013-01-01 |
| Integrative Group-based Cognitive Rehabilitation Efficacy in Multiple Sclerosis (NCT02287454) | University of Deusto | 2013-01-01 |
| Stem Cells in Rapidly Evolving Active Multiple Sclerosis (NCT01606215) | Imperial College London | 2013-01-01 |
| Mesenchymal Cells From Autologous Bone Marrow, Administered Intravenously in Patients Diagnosed With Multiple Sclerosis (NCT01745783) | Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | 2013-01-01 |
| A Pilot Study Assessing the Impact of Gilenya Therapy on Bone Density Change in Relapsing Forms of Multiple Sclerosis (NCT01811290) | Simnad, Virginia, M.D. | 2013-01-01 |
| Transcutaneous Tibial Nerve Stimulation of Patients With Overactive Bladder (OAB) Syndrome (NCT02790307) | University College, London | 2013-01-01 |
| Detecting and Addressing Preclinical Disability (NCT01979081) | McMaster University | 2013-01-01 |
| Improved Detection of Multiple Sclerosis Plaques in Inversion Recovery by Optimization of Sequence Parameters (NCT03108573) | Fondation Ophtalmologique Adolphe de Rothschild | 2012-12-12 |
| Investigating the Relationship Between Sleep, Quality of Life,Other Disorders and Therapies in MS Patients on Betaferon (NCT01766063) | Bayer | 2012-12-06 |
| Efficiency of 4-aminopyridin (Fampyra) on Gait, Vision, Cognition, Fatigue and Micturation in Patients With Multiple Sclerosis (NCT01720849) | Vestre Viken Hospital Trust | 2012-12-01 |
| Avonex-evaluation of Quality of Life and Convenience in Belgian Participants - The AVAIL Study (NCT01272128) | Biogen | 2012-12-01 |
| Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS (NCT01764737) | Vaccinex Inc. | 2012-12-01 |
| Methylphenidate as Treatment Option of Fatigue in Multiple Sclerosis (NCT01879202) | Medical University of Vienna | 2012-12-01 |
| Mesenchymal Stem Cells for Progressive Multiple Sclerosis_Sweden (NCT03778333) | Karolinska Institutet | 2012-12-01 |
| Home Exercise Intervention in Persons With Multiple Sclerosis (NCT01824550) | University of Illinois at Chicago | 2012-11-13 |
| Dose-related Effects of Vitamin D3 on Immune Responses in Patients With Clinically Isolated Syndrome (NCT01728922) | University College Dublin | 2012-11-06 |
| High Dose Chemo With Stem Cell Transplant as Treatment for Multiple Sclerosis That Failed Prior Treatment (NCT01679041) | Seah Lim M.D. | 2012-11-01 |
| Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis (NCT01743651) | RVL Pharmaceuticals, Inc. | 2012-11-01 |
| A Pilot Study to Assess microRNA Biomarkers in Early and Later Stage Multiple Sclerosis (NCT01737372) | John F. Foley, MD | 2012-11-01 |
| Study to Evaluate the Feasibility of [18F]Florbetapir PET for Assessment in MS Patients (NCT01767493) | Institute for Neurodegenerative Disorders | 2012-11-01 |
| Natalizumab Temporary Discontinuation Study (NCT02775110) | University at Buffalo | 2012-11-01 |
| Multiple Sclerosis Produces Cardiovascular Subclinical Dysfunction (NCT03001284) | Carol Davila University of Medicine and Pharmacy | 2012-10-01 |
| Safety and Efficacy Study of Autologus Bone Marrow Mesenchymal Stem Cells in Multiple Sclerosis (NCT01895439) | University of Jordan | 2012-10-01 |
| A 12 -Month, Open-label, Multi-center Study to Explore the Health Outcomes of FTY720 (NCT01578330) | Novartis Pharmaceuticals | 2012-10-01 |
| Evaluation of Coagulation in Multiple Sclerosis (NCT01711255) | Bastyr University | 2012-10-01 |
| Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Normal Population (NCT01804660) | GeNeuro Innovation SAS | 2012-10-01 |
| Measuring Consequences of Disability for Patients With Multiple Sclerosis and Caregivers on Economic Burden (NCT02592265) | Lille Catholic University | 2012-10-01 |
| Vestibular Rehabilitation for Persons With Multiple Sclerosis: Who Benefits the Most? (MSVR3trial) (NCT01698086) | University of Colorado, Denver | 2012-10-01 |
| Exercise in Severely Disabled Patients With MS (NCT01752660) | University of Aarhus | 2012-10-01 |
| Tear Analysis by Isoelectric Focusing in Clinically Isolated Syndrome as Multiple Sclerosis Criterion (NCT02043964) | Lille Catholic University | 2012-10-01 |
| Trichuris Suis Ova (TSO)in Recurrent Remittent Multiple Sclerosis and Clinically Isolated Syndrome (NCT01413243) | Charite University, Berlin, Germany | 2012-09-01 |
| The Effect of Melatonin on Gene Expression and Activity of the Sirt1 and Its Target Genes Catalase and MnSOD in Multiple Sclerosis Patients and Healthy Subjects (NCT02463318) | Tehran University of Medical Sciences | 2012-09-01 |
| Adderall XR and Processing Speed in Multiple Sclerosis (MS) (NCT01667484) | London Health Sciences Centre | 2012-09-01 |
| Study of Alemtuzumab in Treatment Refractory MS Subjects/Alemtuzumab Naive & Alemtuzumab Experienced Subjects (NCT01624714) | Samuel Forrester Hunter, MD, PhD | 2012-09-01 |
| A Study to Evaluate Safety and Efficacy of DC-TAB in Multiple Sclerosis (NCT02442570) | Delta Crystallon BV | 2012-09-01 |
| Expiratory Muscle Conditioning in Multiple Sclerosis Using Magnetic Stimulation (NCT01758224) | The Cleveland Clinic | 2012-09-01 |
| Effectiveness of Ankle Foot Orthoses on Gait in Multiple Sclerosis (NCT01796860) | University of Texas Southwestern Medical Center | 2012-09-01 |
| Assessment of Ocrelizumab (OCR) Treatment Effects on Functional Impairment of MS Patients Enrolled in the Phase III Orchestra Programme Using Multimodal Evoked Potentials (EP) and Highresolution Electroencephalography (EEG) (NCT01765361) | University Hospital, Basel, Switzerland | 2012-09-01 |
| Symptomatic Trigeminal Neuralgia Attributed to Multiple Sclerosis - a Prospective Study in 60 Patients (NCT04371575) | Stine Maarbjerg, MD PhD | 2012-09-01 |
| Assessment of Strategies for the Management of Flu-like Symptoms in MS Patients Commencing Treatment With Betaferon (INFLUENCE) (NCT01706055) | Bayer | 2012-09-01 |
| Evaluation of the Efficiency of a Cognitive Remedial Program (PROCOG-SEP) Designed for Multiple Sclerosis Patients (NCT01659593) | Central Hospital, Nancy, France | 2012-09-01 |
| The Role of Exercise in Modifying Outcomes for People With Multiple Sclerosis (NCT01611987) | McGill University | 2012-09-01 |
| Respiratory Function and Walking Capacity in Multiple Sclerosis (NCT01774201) | Region Örebro County | 2012-09-01 |
| EEG and TMS-based Biomarkers of ALS, MS and FTD (NCT04918251) | University of Dublin, Trinity College | 2012-09-01 |
| Prospective Longitudinal 1-year Study of the Correlation Between Cognitive Functioning in Patients With Clinically Isolated Syndrome Suggestive of Multiple Sclerosis and Disconnection in the Brain Assessed by MRI (NCT01865357) | University Hospital, Bordeaux | 2012-08-24 |
| Relating Genetic and Environmental Risk Scores to Multiple Sclerosis Susceptibility (NCT01617395) | National Institute of Neurological Disorders and Stroke (NINDS) | 2012-08-15 |
| Optical Coherence Tomography in Multiple Sclerosis Patients (NCT01774123) | The Cleveland Clinic | 2012-08-01 |
| Exploratory Study to Assess the Effect of Fampridine (BIIB041) on Walking Ability and Balance in Participants With Multiple Sclerosis. (NCT01597297) | Biogen | 2012-08-01 |
| BRAVE-DREAMS (BRAin VEnous DRainage Exploited Against Multiple Sclerosis) (NCT01371760) | S. Anna Hospital | 2012-08-01 |
| Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis (NCT01684761) | Opexa Therapeutics, Inc. | 2012-08-01 |
| The Effect of Aerobic Exercise on Cognitive Function and Sleep Quality in Individuals With Multiple Sclerosis (NCT01783665) | Catherine Siengsukon, PT, PhD | 2012-08-01 |
| Group Balance Training for People With Multiple Sclerosis (NCT01582126) | Örebro County Council | 2012-08-01 |
| Physical Telerehabilitation in Veterans With Multiple Sclerosis (NCT02346734) | University of Maryland, Baltimore | 2012-07-01 |
| MEsenchymal StEm Cells for Multiple Sclerosis (NCT01854957) | Antonio Uccelli | 2012-07-01 |
| Analysis of Lymphocyte Cell Surface Adhesion Marker Expression in Natalizumab Population With Active Control (NCT01626248) | John F. Foley, MD | 2012-07-01 |
| Validation of Hand Held Dynamometer for Assessment of Lower Limb Muscle Strength in Multiple Sclerosis (NCT01749943) | Brown, Theodore R., M.D., MPH | 2012-07-01 |
| Safety Study of GNbAC1 in Multiple Sclerosis Patients (NCT01639300) | GeNeuro Innovation SAS | 2012-07-01 |
| Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS) (NCT01600716) | Allergan | 2012-06-13 |
| Exploratory Study to Assess Clinical Response to Gilenya® (Fingolimod) in Hispanics With RRMS (NCT01592097) | University of Southern California | 2012-06-01 |
| Peginterferon Beta-1a (BIIB017) Autoinjector Pharmacokinetic Study in Healthy Volunteers (NCT01610310) | Biogen | 2012-06-01 |
| Self Help for Fatigue in Multiple Sclerosis (NCT01532037) | University of Edinburgh | 2012-06-01 |
| Complementary and Alternative Care in Multiple Sclerosis (NCT01703429) | Bastyr University | 2012-06-01 |
| Keratinocyte Growth Factor to Prevent Autoimmunity After Alemtuzumab Treatment of Multiple Sclerosis (NCT01712945) | Cambridge University Hospitals NHS Foundation Trust | 2012-06-01 |
| A Longitudinal Study of Effect of Copaxone in RRMS Over 24 Months (NCT01695434) | University at Buffalo | 2012-06-01 |
| FAME - Fampyra Outcome Measures Study: a Study of Different Outcome Measures on the Effect of Fampyra (NCT01656148) | University of Southern Denmark | 2012-06-01 |
| Project FARMS: Fall Risk Reduction in Multiple Sclerosis (NCT01837017) | University of Illinois at Urbana-Champaign | 2012-06-01 |
| Swiss Multiple Sclerosis Cohort-Study (NCT02433028) | University Hospital, Basel, Switzerland | 2012-06-01 |
| Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis (NCT02907281) | Novartis Pharmaceuticals | 2012-05-29 |
| Assessing Tolerability of Avonex Intramuscular Injections (NCT01641120) | Trinity Health Of New England | 2012-05-01 |
| A Longitudinal Study of Brain Atrophy in MS Patients Over 5 Years (NCT01847287) | University at Buffalo | 2012-05-01 |
| Noninterventional Study Assessing Cognitive Function and Physical Activity in People With Multiple Sclerosis (NCT01491100) | Bayer | 2012-04-30 |
| Dietary Supplement of Curcumin in Subjects With Active Relapsing Multiple Sclerosis Treated With Subcutaneous Interferon Beta 1a (NCT01514370) | Merck KGaA, Darmstadt, Germany | 2012-04-30 |
| STudy to vAlidate telemetRic ECG Systems for firsT Dose Administration of Fingolimod (START) (NCT01585298) | Novartis Pharmaceuticals | 2012-04-29 |
| An Observational Study to Collect Information on Safety and to Document the Drug Utilization of Fampyra (BIIB041) When Used In Routine Medical Practice (NCT01480063) | Biogen | 2012-04-16 |
| Functional Changes Following Percutaneous Venoplasty in Multiple Sclerosis Patients (NCT01555684) | University of Stirling | 2012-04-01 |
| Analyze the Myelin-TRAP as Diagnostic Tool in Multiple Sclerosis (NCT01723631) | Nantes University Hospital | 2012-04-01 |
| Neurophysiological Study of Sativex in Multiple Sclerosis (MS) Spasticity (NCT01538225) | Almirall, S.A. | 2012-04-01 |
| Study to Evaluate the Reduction of Cardiac Problems in Multiple Sclerosis Patients With Mitoxantrone and Dexrazoxane in Combination (NCT01627938) | PD Dr. Andrew Chan | 2012-04-01 |
| Using Optical Coherence Tomography to Capture Retinal Microvascular Changes Associated With Multiple Sclerosis (NCT01596881) | Oregon Health and Science University | 2012-04-01 |